½ÃÀ庸°í¼­
»óǰÄÚµå
1517327

¼¼°èÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå ±Ô¸ð Á¶»ç : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)

Global Nephrology and Urology Devices Market Size Study, by Product Type, by Application, by End User and Regional Forecasts 2022-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀåÀº 2023³â 327¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2023-2032³â ¿¹Ãø ±â°£ µ¿¾È 4.5% ÀÌ»óÀÇ °ßÁ¶ÇÑ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀåÀº ÁÖ·Î ¸¸¼º ½ÅÀå Áúȯ(CKD)°ú ¸»±â ½ÅÀå Áúȯ(ESRD)ÀÇ À¯º´·ü Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ(CDC)¿¡ µû¸£¸é, ¸¸¼ºÄáÆÏº´ À¯º´·üÀº ³²¼º(12%)¿¡ ºñÇØ ¿©¼º(14%)ÀÌ ´Ù¼Ò ³ôÀº °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ±× °á°ú, ½ÅÀå Áúȯ ¹× ±âŸ ºñ´¢±â°ú ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ½ÅÀåÇÐ ¹× ºñ´¢±â°ú Àåºñ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÀå ¹× ºñ´¢±â°ú ÁúȯÀÇ Á¶±â Áø´Ü ¹× Ä¡·áÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¼±º° ¹× Áø´Ü Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ½ÅÀåÇÐ Àåºñ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ ½ÅÀå ±â±Ý(American Kidney Fund)Àº ¸¸¼º ½ÅÀå Áúȯ °ËÁøÀÇ È°¿ëÀ» È®´ëÇϰí Èñ±Í ½ÅÀå ÁúȯÀÇ Áø´Ü°ú ¿¹¹æÀ» °³¼±Çϱâ À§ÇÑ ÀÓ»ó ¿¬±¸, ÀÇ·áÁø ±³À°, Èñ±Í ½ÅÀå Áúȯ Áø´Ü ¹× ¿¹¹æ Á¤Ã¥À» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀçÅà Åõ¼® ¼Ö·ç¼Ç ¹× ÈÞ´ë¿ë ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå ¼ºÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¸¸¼º ½ÅÀå Áúȯ, ½ÅÀå °á¼®, ¿ä½Ç±Ý, ºñ´¢±â¾Ï°ú °°Àº ÁúȯÀÇ ¹ßº´·ü Áõ°¡·Î ÀÎÇØ ½ÅÀå ¹× ºñ´¢±â ÀåÄ¡ ¹× Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ºÐ¼® ±â°£ µ¿¾È ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ ÃÖ¼Òħ½À ¼ö¼ú±â±¸, ·Îº¿ º¸Á¶ ¼ö¼ú, Áø´Ü µµ±¸ÀÇ °³¼± µî ÀÇ·á±â±âÀÇ Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀº ȯÀÚ Ä¡·á °á°ú¸¦ °³¼±ÇÏ°í ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ÇÁ·¹Á¦´Ï¿ì½º ¸ÞµðÄà Äɾî(Fresenius Medical Care)ÀÇ 6008 ½Ã¸®Áî Ç÷¾× Åõ¼®±â´Â Á¤È®ÇÑ Åõ¼® Ä¡·á¸¦ À§ÇÑ Ã·´Ü ±â´ÉÀ» Á¦°øÇÏ¿© ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎ¿¡°Ô Åõ¼® °æÇèÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ºñ´¢±â°ú ±â±â´Â °í°¡À̱⠶§¹®¿¡ ƯÈ÷ ¾Æ½Ã¾ÆÅÂÆò¾ç°ú °°ÀÌ °¡°Ý¿¡ ¹Î°¨ÇÑ Áö¿ª¿¡¼­´Â ½ÃÀå ¼ºÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ºñ´¢±â ³»½Ã°æ°ú ¿£µåºñÀü ½Ã½ºÅÛÀÇ ³ôÀº ºñ¿ëÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºñ´¢±â°ú ±â±â¸¦ Á¶ÀÛÇϰí À¯Áöº¸¼öÇÒ ¼ö ÀÖ´Â ¼÷·ÃµÈ Àü¹®°¡°¡ ºÎÁ·ÇÏ´Ù´Â Á¡µµ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â Áß¿äÇÑ ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

½ÅÀå ¹× ºñ´¢±â ±â±â ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â 2023³â ¸ÅÃâ ±âÁØÀ¸·Î ½ÃÀåÀ» Áö¹èÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ÁÖ·Î ¼±ÁøÈ­µÈ ÀÇ·á ÀÎÇÁ¶ó, ½ÅÀå ¹× ¿ä·Î ÁúȯÀÇ ³ôÀº À¯º´·ü, ¿¬±¸°³¹ß¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ Áö¿ªÀº ÀÇ·á ½Ã¼³ÀÌ Àß °®Ãß¾îÁ® ÀÖ°í ¼÷·ÃµÈ ÀÇ·á ÀηÂÀ» º¸À¯Çϰí ÀÖ¾î Çõ½ÅÀûÀÎ ½ÅÀå ¹× ºñ´¢±â Ä¡·á Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¹Ì±¹Àº ¸¸¼ºÄáÆÏº´(CKD)°ú ºñ´¢±â ÁúȯÀÇ ³ôÀº ¹ßº´·ü°ú °í±Þ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä·Î ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À¯¸®ÇÑ »óȯ Á¤Ã¥°ú Á¤ºÎ ¹× ¹Î°£ ÀÇ·á±â°üÀÇ °­·ÂÇÑ Áö¿øÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ÀÇ·á±â±â Á¦Á¶¾÷üÀÇ Á¸Àç¿Í Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀüÀº ÀÌ Áö¿ªÀÇ ½ÃÀå Áö¹è·ÂÀ» ´õ¿í °­È­Çϰí ÀÖ½À´Ï´Ù. ½ÅÀå ¹× ºñ´¢±â ÁúȯÀÇ Á¶±â Áø´Ü ¹× Ä¡·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í °í·ÉÈ­ »çȸ·Î Á¢¾îµé¸é¼­ ºÏ¹ÌÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾Æ½Ã¾ÆÅÂÆò¾çÀº 2024-2032³â ¿¹Ãø ±â°£ µ¿¾È Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÅÀå ¹× ºñ´¢±â ±â±â ¼¼°è ½ÃÀå : ÁÖ¿ä ¿ä¾à

  • ½ÅÀå ¹× ºñ´¢±â ±â±â ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2032³â)
  • Áö¿ªº° °³¿ä
  • ºÎ¹®º° °³¿ä
    • Á¦Ç°º°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • ÁÖ¿ä µ¿Çâ
  • °æ±âÈÄÅðÀÇ ¿µÇâ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È

Á¦2Àå ¼¼°èÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå Á¤ÀÇ¿Í Á¶»ç °¡Á¤

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ
  • Á¶»ç °¡Á¤
    • Æ÷ÇÔ°ú Á¦¿Ü
    • Á¦ÇÑ»çÇ×
    • °ø±ÞÃø ºÐ¼®
      • ÀÔ¼ö °¡´É¼º
      • ÀÎÇÁ¶ó
      • ±ÔÁ¦ ȯ°æ
      • ½ÃÀå °æÀï
      • °æÁ¦¼º(¼ÒºñÀÚÀÇ °üÁ¡)
    • ¼ö¿äÃø ºÐ¼®
      • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
      • ±â¼úÀÇ Áøº¸
      • ģȯ°æ
      • ¼ÒºñÀÚ Àǽİú ¼ö¿ë
  • Á¶»ç ¹æ¹ý
  • Á¶»ç ´ë»ó ¿¬µµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ½ÅÀå ¹× ºñ´¢±â ±â±â ¼¼°è ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼º½ÅÀ庴(CKD)¡¤¸»±â ½ÅÀ庴(ESRD) À¯º´·ü »ó½Â
    • ÀÇ·á±â±â¿Í ±â¼úÀÇ Áøº¸
    • Á¶±â Áø´Ü°ú Ä¡·á¿¡ ´ëÇÑ ÀÎ½Ä È®»ê
  • ½ÃÀå °úÁ¦
    • ºñ´¢±â ÀÇ·á±â±âÀÇ °íºñ¿ë
    • ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·
  • ½ÃÀå ±âȸ
    • ÀçÅà Åõ¼® ¼Ö·ç¼Ç ¼ö¿ä
    • ±â±â ±â¼ú Çõ½Å

Á¦4Àå ¼¼°èÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå : »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è
    • Porter's Five Forces ¸ðµ¨·ÎÀÇ ¹Ì·¡ÁöÇâÀû Á¢±Ù¹ý
    • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °üÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È

Á¦5Àå ½ÅÀå ¹× ºñ´¢±â ±â±â ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Á¦Ç°º°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ½ÅÀå ¹× ºñ´¢±â ±â±â ¼¼°è ½ÃÀå : Á¦Ç°º°, ¸ÅÃâ µ¿Ç⠺м®, 2022³â¡¤2032³â
    • ±â±â
    • ¼Ò¸ðǰ¡¤¾×¼¼¼­¸®

Á¦6Àå ½ÅÀå ¹× ºñ´¢±â ±â±â ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ¿ëµµº°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ½ÅÀå ¹× ºñ´¢±â ±â±â ¼¼°è ½ÃÀå : ¿ëµµº°, ¸ÅÃâ µ¿Ç⠺м®, 2022³â¡¤2032³â
    • ½ÅÀåÁúȯ
    • ºñ´¢±â¾Ï¡¤BPH
    • ±âŸ

Á¦7Àå ½ÅÀå ¹× ºñ´¢±â ±â±â ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ½ÅÀå ¹× ºñ´¢±â ±â±â ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ¸ÅÃâ µ¿Ç⠺м®, 2022³â¡¤2032³â
    • º´¿ø
    • Åõ¼® ¼¾ÅÍ
    • ±âŸ

Á¦8Àå ½ÅÀå ¹× ºñ´¢±â ±â±â ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°, 2022-2032³â

  • ºÏ¹ÌÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • ¹Ì±¹ÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • ij³ª´ÙÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • ¸ß½ÃÄÚÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
  • À¯·´ÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • ¿µ±¹ÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • µ¶ÀÏÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • ÇÁ¶û½ºÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • ÀÌÅ»¸®¾ÆÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • ½ºÆäÀÎÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • ±âŸ À¯·´ÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • Áß±¹ÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • ÀϺ»ÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • ÀεµÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • Çѱ¹ÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • È£ÁÖÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • ºê¶óÁúÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • ¸ß½ÃÄÚÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • »ç¿ìµð¾Æ¶óºñ¾ÆÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Medtronic plc
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ °¡¿ë¼º¿¡ µû¶ó ´Ù¸§)
      • Á¦Ç° °³¿ä
      • ½ÃÀå Àü·«
    • Boston Scientific Corporation
    • B. Braun SE
    • Baxter International Inc.
    • Coloplast
    • Olympus Corporation
    • Stryker Corporation
    • Teleflex Incorporated
    • Becton, Dickinson and Company
    • Karl Storz GmbH & Co. KG
    • STERIS
    • Advin Health Care
    • Narang Medical Limited

Á¦10Àå Á¶»ç °úÁ¤

ksm 24.08.02

The Global Nephrology and Urology Devices Market was valued at USD 32.71 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.5% over the forecast period 2023-2032. The market for nephrology and urology devices is primarily driven by the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD). According to the Centers for Disease Control and Prevention (CDC), chronic kidney disease is slightly more prevalent in women (14%) compared to men (12%). Consequently, the growing incidence of kidney diseases and other urological conditions has increased the demand for nephrology and urology devices, thereby propelling market growth during the forecast period. Additionally, increased awareness of the importance of early diagnosis and treatment of kidney and urology disorders has led to higher demand for screening and diagnostic devices, further driving the nephrology devices market growth. The American Kidney Fund supports policies to expand the use of chronic kidney disease screening and improve clinical research, provider training, and diagnosis and prevention of rare kidney diseases. Furthermore, the increasing demand for home-based dialysis solutions and portable devices provides a lucrative opportunity for the nephrology and urology devices market growth.

The rise in the incidence of conditions such as chronic kidney disease, kidney stones, urinary incontinence, and urological cancers has created a high demand for devices and treatments in nephrology and urology. This trend drives market growth during the nephrology and urology devices market analysis period. Furthermore, ongoing innovations in medical devices, such as minimally invasive surgical instruments, robotic-assisted surgeries, and improved diagnostic tools, have enhanced patient outcomes and boosted market growth. For example, Fresenius Medical Care's 6008 Series Hemodialysis Machines offer advanced features for precise dialysis treatment, enhancing the overall dialysis experience for both patients and healthcare providers. These advancements have fueled the growth of the nephrology and urology devices market. However, the high cost of urology devices negatively impacts market growth, particularly in price-sensitive regions such as Asia-Pacific. The high cost of urology endoscopes and endovision systems may hamper market growth. In addition, the lack of skilled professionals to operate and maintain urology devices is a significant factor that may restrain market growth.

The key regions considered for the Global Nephrology and Urology Devices Market study include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America dominates the market in 2023 in terms of revenue. This is primarily due to its advanced healthcare infrastructure, high prevalence of kidney and urinary tract diseases, and significant investment in research and development. The region's well-established healthcare facilities and the availability of skilled healthcare professionals drive the demand for innovative nephrology and urology devices. The United States, in particular, leads the market with its high incidence of chronic kidney disease (CKD) and urological disorders, necessitating advanced treatment options. Additionally, favorable reimbursement policies and strong support from government and private healthcare organizations boost market growth. The presence of major medical device manufacturers and continuous technological advancements further enhance the region's market dominance. Increasing awareness about early diagnosis and treatment of kidney and urinary conditions, along with a growing aging population, also contribute to the rising demand for nephrology and urology devices in North America. Furthermore, Asia Pacific is projected to grow significantly during the forecast period 2024-2032.

Major market players included in this report are:

  • Medtronic plc
  • Boston Scientific Corporation
  • B. Braun SE
  • Baxter International Inc.
  • Coloplast
  • Olympus Corporation
  • Stryker Corporation
  • Teleflex Incorporated
  • Becton, Dickinson and Company
  • Karl Storz GmbH & Co. KG
  • STERIS
  • Advin Health Care
  • Narang Medical Limited

The detailed segments and sub-segment of the market are explained below:

By Product:

  • Instruments
  • Consumables & Accessories

By Application:

  • Kidney Diseases
  • Urological Cancer & BPH
  • Others

By End User:

  • Hospitals
  • Dialysis Centers
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Nephrology and Urology Devices Market Executive Summary

  • 1.1. Global Nephrology and Urology Devices Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product
    • 1.3.2. By Application
    • 1.3.3. By End User
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Nephrology and Urology Devices Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Nephrology and Urology Devices Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD)
    • 3.1.2. Advancements in medical devices and technologies
    • 3.1.3. Increasing awareness about early diagnosis and treatment
  • 3.2. Market Challenges
    • 3.2.1. High cost of urology devices
    • 3.2.2. Lack of skilled professionals
  • 3.3. Market Opportunities
    • 3.3.1. Demand for home-based dialysis solutions
    • 3.3.2. Technological innovations in devices

Chapter 4. Global Nephrology and Urology Devices Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Nephrology and Urology Devices Market Size & Forecasts by Product 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Nephrology and Urology Devices Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Instruments
    • 5.2.2. Consumables and Accessories

Chapter 6. Global Nephrology and Urology Devices Market Size & Forecasts by Application 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Nephrology and Urology Devices Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Kidney Diseases
    • 6.2.2. Urological Cancer and BPH
    • 6.2.3. Others

Chapter 7. Global Nephrology and Urology Devices Market Size & Forecasts by End User 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Nephrology and Urology Devices Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 7.2.1. Hospitals
    • 7.2.2. Dialysis Centers
    • 7.2.3. Others

Chapter 8. Global Nephrology and Urology Devices Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Nephrology and Urology Devices Market
    • 8.1.1. U.S. Nephrology and Urology Devices Market
      • 8.1.1.1. Product breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Application breakdown size & forecasts, 2022-2032
      • 8.1.1.3. End User breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Nephrology and Urology Devices Market
      • 8.1.2.1. Product breakdown size & forecasts, 2022-2032
      • 8.1.2.2. Application breakdown size & forecasts, 2022-2032
      • 8.1.2.3. End User breakdown size & forecasts, 2022-2032
    • 8.1.3. Mexico Nephrology and Urology Devices Market
      • 8.1.3.1. Product breakdown size & forecasts, 2022-2032
      • 8.1.3.2. Application breakdown size & forecasts, 2022-2032
      • 8.1.3.3. End User breakdown size & forecasts, 2022-2032
  • 8.2. Europe Nephrology and Urology Devices Market
    • 8.2.1. U.K. Nephrology and Urology Devices Market
      • 8.2.1.1. Product breakdown size & forecasts, 2022-2032
      • 8.2.1.2. Application breakdown size & forecasts, 2022-2032
      • 8.2.1.3. End User breakdown size & forecasts, 2022-2032
    • 8.2.2. Germany Nephrology and Urology Devices Market
      • 8.2.2.1. Product breakdown size & forecasts, 2022-2032
      • 8.2.2.2. Application breakdown size & forecasts, 2022-2032
      • 8.2.2.3. End User breakdown size & forecasts, 2022-2032
    • 8.2.3. France Nephrology and Urology Devices Market
      • 8.2.3.1. Product breakdown size & forecasts, 2022-2032
      • 8.2.3.2. Application breakdown size & forecasts, 2022-2032
      • 8.2.3.3. End User breakdown size & forecasts, 2022-2032
    • 8.2.4. Italy Nephrology and Urology Devices Market
      • 8.2.4.1. Product breakdown size & forecasts, 2022-2032
      • 8.2.4.2. Application breakdown size & forecasts, 2022-2032
      • 8.2.4.3. End User breakdown size & forecasts, 2022-2032
    • 8.2.5. Spain Nephrology and Urology Devices Market
      • 8.2.5.1. Product breakdown size & forecasts, 2022-2032
      • 8.2.5.2. Application breakdown size & forecasts, 2022-2032
      • 8.2.5.3. End User breakdown size & forecasts, 2022-2032
    • 8.2.6. Rest of Europe Nephrology and Urology Devices Market
      • 8.2.6.1. Product breakdown size & forecasts, 2022-2032
      • 8.2.6.2. Application breakdown size & forecasts, 2022-2032
      • 8.2.6.3. End User breakdown size & forecasts, 2022-2032
  • 8.3. Asia-Pacific Nephrology and Urology Devices Market
    • 8.3.1. China Nephrology and Urology Devices Market
      • 8.3.1.1. Product breakdown size & forecasts, 2022-2032
      • 8.3.1.2. Application breakdown size & forecasts, 2022-2032
      • 8.3.1.3. End User breakdown size & forecasts, 2022-2032
    • 8.3.2. Japan Nephrology and Urology Devices Market
      • 8.3.2.1. Product breakdown size & forecasts, 2022-2032
      • 8.3.2.2. Application breakdown size & forecasts, 2022-2032
      • 8.3.2.3. End User breakdown size & forecasts, 2022-2032
    • 8.3.3. India Nephrology and Urology Devices Market
      • 8.3.3.1. Product breakdown size & forecasts, 2022-2032
      • 8.3.3.2. Application breakdown size & forecasts, 2022-2032
      • 8.3.3.3. End User breakdown size & forecasts, 2022-2032
    • 8.3.4. South Korea Nephrology and Urology Devices Market
      • 8.3.4.1. Product breakdown size & forecasts, 2022-2032
      • 8.3.4.2. Application breakdown size & forecasts, 2022-2032
      • 8.3.4.3. End User breakdown size & forecasts, 2022-2032
    • 8.3.5. Australia Nephrology and Urology Devices Market
      • 8.3.5.1. Product breakdown size & forecasts, 2022-2032
      • 8.3.5.2. Application breakdown size & forecasts, 2022-2032
      • 8.3.5.3. End User breakdown size & forecasts, 2022-2032
    • 8.3.6. Rest of Asia-Pacific Nephrology and Urology Devices Market
      • 8.3.6.1. Product breakdown size & forecasts, 2022-2032
      • 8.3.6.2. Application breakdown size & forecasts, 2022-2032
      • 8.3.6.3. End User breakdown size & forecasts, 2022-2032
  • 8.4. Latin America Nephrology and Urology Devices Market
    • 8.4.1. Brazil Nephrology and Urology Devices Market
      • 8.4.1.1. Product breakdown size & forecasts, 2022-2032
      • 8.4.1.2. Application breakdown size & forecasts, 2022-2032
      • 8.4.1.3. End User breakdown size & forecasts, 2022-2032
    • 8.4.2. Mexico Nephrology and Urology Devices Market
      • 8.4.2.1. Product breakdown size & forecasts, 2022-2032
      • 8.4.2.2. Application breakdown size & forecasts, 2022-2032
      • 8.4.2.3. End User breakdown size & forecasts, 2022-2032
    • 8.4.3. Rest of Latin America Nephrology and Urology Devices Market
      • 8.4.3.1. Product breakdown size & forecasts, 2022-2032
      • 8.4.3.2. Application breakdown size & forecasts, 2022-2032
      • 8.4.3.3. End User breakdown size & forecasts, 2022-2032
  • 8.5. Middle East & Africa Nephrology and Urology Devices Market
    • 8.5.1. Saudi Arabia Nephrology and Urology Devices Market
      • 8.5.1.1. Product breakdown size & forecasts, 2022-2032
      • 8.5.1.2. Application breakdown size & forecasts, 2022-2032
      • 8.5.1.3. End User breakdown size & forecasts, 2022-2032
    • 8.5.2. South Africa Nephrology and Urology Devices Market
      • 8.5.2.1. Product breakdown size & forecasts, 2022-2032
      • 8.5.2.2. Application breakdown size & forecasts, 2022-2032
      • 8.5.2.3. End User breakdown size & forecasts, 2022-2032
    • 8.5.3. Rest of Middle East & Africa Nephrology and Urology Devices Market
      • 8.5.3.1. Product breakdown size & forecasts, 2022-2032
      • 8.5.3.2. Application breakdown size & forecasts, 2022-2032
      • 8.5.3.3. End User breakdown size & forecasts, 2022-2032

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Medtronic plc
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. Boston Scientific Corporation
    • 9.3.3. B. Braun SE
    • 9.3.4. Baxter International Inc.
    • 9.3.5. Coloplast
    • 9.3.6. Olympus Corporation
    • 9.3.7. Stryker Corporation
    • 9.3.8. Teleflex Incorporated
    • 9.3.9. Becton, Dickinson and Company
    • 9.3.10. Karl Storz GmbH & Co. KG
    • 9.3.11. STERIS
    • 9.3.12. Advin Health Care
    • 9.3.13. Narang Medical Limited

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦